A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3694-5 ◽

2018 ◽

Vol 82 (6) ◽

pp. 1031-1038 ◽

Author(s):

Naohiro Oda ◽

Kastuyuki Hotta ◽

Kiichiro Ninomiya ◽

Daisuke Minami ◽

Eiki Ichihara ◽

...

Keyword(s):

Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Egfr Tki ◽

Download Full-text

Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702

Lung Cancer ◽

10.1016/j.lungcan.2015.04.012 ◽

2015 ◽

Vol 89 (1) ◽

pp. 61-65 ◽

Author(s):

Akira Inoue ◽

Shunichi Sugawara ◽

Makoto Maemondo ◽

Yoshiaki Mori ◽

Satoshi Oizumi ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Randomized Phase Ii ◽

Group Trial ◽

Platinum Doublet

Download Full-text

A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small cell lung cancer with wild-type EGFR: The Okayama Lung Cancer Study Group Trial 1202 (OLCSG1202)

Annals of Oncology ◽

10.1093/annonc/mdx671.044 ◽

2017 ◽

Vol 28 ◽

pp. x139-x140

Author(s):

A. Bessho ◽

N. Ochi ◽

S. Kuyama ◽

T. Umeno ◽

G. Ikeda ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Phase Ii Trial ◽

Study Group ◽

Wild Type ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2004.05.030 ◽

2005 ◽

Vol 129 (5) ◽

pp. 977-983 ◽

Author(s):

Ryosuke Tsuchiya ◽

Kenji Suzuki ◽

Yukito Ichinose ◽

Yoh Watanabe ◽

Tsutomu Yasumitsu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Resected Stage ◽

Download Full-text

A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181c20063 ◽

2010 ◽

Vol 5 (1) ◽

pp. 99-104 ◽

Author(s):

Hiroshige Yoshioka ◽

Katsuyuki Hotta ◽

Katsuyuki Kiura ◽

Nagio Takigawa ◽

Hidetoshi Hayashi ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Egfr Mutations ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Pretreated Patients ◽

Download Full-text

Faculty Opinions recommendation of Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1137910.595009 ◽

2008 ◽

Author(s):

Nico van Zandwijk

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Randomized Phase Ii ◽

Previously Treated ◽

Download Full-text

9070 Phase II trial of S-1 with bi-weekly docetaxel for non-small-cell lung cancer previously treated with platinum-based chemotherapy: a North Japan Lung Cancer Study Group (NJLCG0701)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71783-5 ◽

2009 ◽

Vol 7 (2) ◽

pp. 526

Author(s):

M. Maemondo ◽

O. Ishimoto ◽

A. Inoue ◽

N. Matsubara ◽

N. Morikawa ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Small Cell Lung ◽

Weekly Docetaxel ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Platinum Based Chemotherapy ◽

Previously Treated

Download Full-text

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404

Lung Cancer ◽

10.1016/j.lungcan.2017.11.025 ◽

2018 ◽

Vol 115 ◽

pp. 103-108 ◽

Author(s):

Takashi Ninomiya ◽

Naoyuki Nogami ◽

Toshiyuki Kozuki ◽

Daijiro Harada ◽

Toshio Kubo ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Phase I Trial ◽

Egfr Mutations ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

Faculty Opinions recommendation of Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10187956.10976054 ◽

2011 ◽

Author(s):

Elizabeth Gore

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.07.003 ◽

2017 ◽

Vol 18 (2) ◽

pp. 241-244 ◽

Author(s):

Naohiro Oda ◽

Eiki Ichihara ◽

Katsuyuki Hotta ◽

Kiichiro Ninomiya ◽

Takashi Ninomiya ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Egfr Mutation ◽

Advanced Nsclc ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Egfr Tki ◽

Download Full-text

A Phase II Study of Cisplatin (P), S-1 (S) and Concurrent Thoracic Radiotherapy (TRT) for Locally Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): Okayama Lung Cancer Study Group Trial 0501

Annals of Oncology ◽

10.1016/s0923-7534(20)32313-9 ◽

2012 ◽

Vol 23 ◽

pp. xi115

Author(s):

N. Nogami ◽

T. Kozuki ◽

Y. Segawa ◽

T. Shinkai ◽

T. Maeda ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Study Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text